Hematopoietic Stem Cell Transplantation for Fanconi Anemia: A Single Center Experience from India.

Fanconi anemia HSCT Matched sibling donor

Journal

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
ISSN: 0971-4502
Titre abrégé: Indian J Hematol Blood Transfus
Pays: India
ID NLM: 9425818

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 16 09 2019
accepted: 14 01 2020
entrez: 11 7 2020
pubmed: 11 7 2020
medline: 11 7 2020
Statut: ppublish

Résumé

Hematopoietic stem cell transplantation (HSCT) is the only treatment option for the hematological manifestations of Fanconi anemia (FA). Fludarabine based reduced intensity conditioning regimens have helped in improving outcomes significantly in FA patients. We retrospectively analyzed the outcomes of FA patients who underwent allogeneic HSCT at BLK Superspeciality Hospital, New Delhi from June 2011 to September 2019. Twenty FA patients underwent 23 transplants at our center. Overall survival and disease free survival were 65% and 50%, respectively at a median of 23 months. Overall mortality was 30%. HSCT for FA is a feasible option even in developing countries although children present late to transplant centers after multiple transfusions and infections.

Identifiants

pubmed: 32647434
doi: 10.1007/s12288-020-01254-3
pii: 1254
pmc: PMC7326841
doi:

Types de publication

Journal Article

Langues

eng

Pagination

565-568

Informations de copyright

© Indian Society of Hematology and Blood Transfusion 2020.

Déclaration de conflit d'intérêts

Conflict of interestAll authors declare that they have no conflict of interest.

Références

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):285-289
pubmed: 28644950
Br J Haematol. 2016 Sep;174(6):952-61
pubmed: 27470218
Expert Rev Hematol. 2017 Jan;10(1):81-97
pubmed: 27929686
Br J Haematol. 2010 Apr;149(1):14-21
pubmed: 20136826
Blood. 2013 Dec 19;122(26):4279-86
pubmed: 24144640
Blood. 2015 Jan 8;125(2):417-8
pubmed: 25573976
Blood. 2007 Mar 1;109(5):2256-62
pubmed: 17038525
Mutat Res. 2009 Jul 31;668(1-2):4-10
pubmed: 19622403
Haematologica. 2007 Oct;92(10):1381-8
pubmed: 18024375

Auteurs

Divya Doval (D)

Department of Hemato-Oncology and Bone Marrow Transplantation, BLK Superspeciality Hospital, New Delhi, 110005 India.

Dharma Choudhary (D)

Department of Hemato-Oncology and Bone Marrow Transplantation, BLK Superspeciality Hospital, New Delhi, 110005 India.

Sanjeev Kumar Sharma (SK)

Department of Hemato-Oncology and Bone Marrow Transplantation, BLK Superspeciality Hospital, New Delhi, 110005 India.

Vipin Khandelwal (V)

Department of Hemato-Oncology and Bone Marrow Transplantation, BLK Superspeciality Hospital, New Delhi, 110005 India.

Meet Kumar (M)

Department of Hemato-Oncology and Bone Marrow Transplantation, BLK Superspeciality Hospital, New Delhi, 110005 India.

Anil Handoo (A)

Laboratory Services, Department of Haematology, BLK Superspeciality Hospital, New Delhi, 110005 India.

Rasika Setia (R)

Transfusion Medicine, BLK Superspeciality Hospital, New Delhi, 110005 India.

Classifications MeSH